Neumora Therapeutics Financial Ratios for Analysis 2022-2024 | NMRA

Fifteen years of historical annual and quarterly financial ratios and margins for Neumora Therapeutics (NMRA).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
19.0516.37
--
--
--
--
--
--
--
--
--
--
--
--
-50.3029.29
-50.30-32.99
-47.55-30.71
-50.30-32.99
2.9512.17
-2.51-4.22
-2.51-4.24

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-30
10.9817.2217.9919.0518.05----
---------
---------
---------
---------
---------
---------
---------
---------
---------
---------
---------
---------
-22.62-15.40-12.65-23.18-10.34----
-22.62-15.40-12.65-23.18-10.34----
-20.58-14.51-11.93-21.91-9.73----
-22.62-15.40-12.65-23.18-10.34----
2.002.382.662.953.36----
-0.83-0.62-0.27-2.51-2.40-2.13-1.130.00-3.06
-0.83-0.62-0.27-2.51-2.40-2.13-1.13--3.08